Protection against beta-amyloid-induced apoptosis by peptides interacting with beta-amyloid

Thomas J Nelson1, Daniel L Alkon

  • 1Blanchette Rockefeller Neurosciences Institute, Rockville, Maryland 20850, USA. tjnelson@brni-jhu.org

Insights

Beta-amyloid peptide toxicity in neurons is linked to its interaction with cholesterol transport proteins. Blocking specific beta-amyloid regions with peptides may prevent neuronal damage.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Molecular Biology

Background:

  • The mechanism of beta-amyloid peptide-induced neuronal apoptosis remains unclear.
  • The physiological role of beta-amyloid peptide is currently unknown.
  • Understanding beta-amyloid's interactions is crucial for Alzheimer's disease research.

Purpose of the Study:

  • To identify the protein-protein interactions and biochemical receptors for beta-amyloid peptide in the brain.
  • To elucidate the normal biological function of beta-amyloid peptide.
  • To discover potential therapeutic targets for blocking beta-amyloid toxicity.

Main Methods:

  • Utilized phage display, co-precipitation, and mass spectrometry to analyze beta-amyloid interactions.
  • Examined protein-protein binding in normal rabbit brain tissue.
  • Synthesized and tested peptides for their ability to block beta-amyloid's toxic effects.

Main Results:

  • Beta-amyloid peptide primarily binds to proteins involved in cholesterol and lipoprotein transport, including sortilin, ERGIC2, ERGIC-53, steroid 5alpha-reductase, and apolipoprotein B.
  • Beta-amyloid also interacts with C-reactive protein (inflammation) and 14-3-3 (regulating tau phosphorylation kinase).
  • Three synthetic peptides targeting beta-amyloid's hydrophobic region (residues 17-21) or pseudo-phosphorylation site (residues 26-30) effectively blocked neuronal toxicity.

Conclusions:

  • Beta-amyloid peptide's toxic effects may stem from its interactions with cholesterol transport and inflammatory pathways.
  • Specific regions of beta-amyloid are critical for its biological activity and aggregation.
  • Therapeutic strategies targeting these critical regions could offer neuroprotection against beta-amyloid toxicity.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.